⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8941285 | 0.82 | FABP3 (0.46) | — | |
| SCHEMBL17452138 | 0.77 | — | — | |
| SCHEMBL2458583 | 0.76 | — | — | |
| SCHEMBL9059769 | 0.76 | FAAH (0.41) | — | |
| SCHEMBL1927023 | 0.74 | SCN5A (0.49) | — | |
| SCHEMBL4875993 | 0.73 | CA1 (0.45) | — | |
| SCHEMBL107196 | 0.73 | — | — | |
| SCHEMBL7568858 | 0.73 | — | — | |
| SCHEMBL8962422 | 0.72 | LMNA (0.44) | — | |
| SCHEMBL9945774 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1996019444-A1 | SULFONATE ACAT INHIBITORS | WARNER-LAMBERT COMPANY (US) | 1996-06-27 | — | — | WO | disclosed |
| US-5510379-A | USEFUL FOR TREATING HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS | WARNER-LAMBERT COMPANY (US) | 1996-04-23 | — | — | US | disclosed |